Josep Carreras Leukaemia Research Institute
🔬 International research institute advancing studies on #leukaemia, #lymphoma, and other #hemopathies.
Centre of Exellence Severo Ochoa and @cerca.cat
🌐 Explore our work at carrerasresearch.org/en
- The @achilles-dn.bsky.social, coordinated by Dr Laura Belver, brings together 15 centres in 12 countries to train PhD researchers in experimental haemato-oncology and accelerate translational blood cancer research. 🔗 Learn more: www.carrerasresearch.org/en/news/the-...
- 📢 Join us on Monday 9 Feb 2026 for a high-level symposium on Follicular Lymphoma! The symposium will bring together leading experts to share discoveries and drive projects that improve treatments and quality of life of patients with FL. 👉 Register in-person or online: forms.office.com/e/Cqix1YVB8b
- Un placer recibir la visita de CRIS contra el Cáncer en el IJC. Intercambiamos visiones, compartimos nuestro plan estratégico e iniciativas clave y exploramos cómo unir fuerzas para acelerar el impacto frente a los cánceres de la sangre 🔬 🤝
- 🔬 Dr Alex Vaquero (@vaquerolab.bsky.social) will study the restoration of PAX5 balance in leukemic cells as a new tool in the fight against B-ALL thanks to the support from @caixaresearch.bsky.social 🙌 Know more about their project 👇 www.carrerasresearch.org/en/news/rest...
- ¿Qué avances científicos nos esperan en el ámbito del envejecimiento? No te pierdas la mesa redonda “El reto de hacerse mayor” para descubrir cómo la ciencia está cambiando nuestra forma de envejecer. 📅 6 Nov, 18:30 📍 Auditorio @the_prbb BCN 🎟️ Entrada libre 👩🔬Moderado por @vrodillab.bsky.social
- The Josep Carreras Institute made its mark at #BIOSPAIN2025! Our team fostered key collaborations 🤝, shared new leadership initiatives 💡and reinforced IJC’s position as a leading centre in #BloodCancer research 🔬 🔗 www.carrerasresearch.org/en/news/the-...
- We’re proud to host the 2nd @securedproject.bsky.social Demonstration Workshop at IJC on 3-4 December! A unique opportunity for research, healthcare and cybersecurity experts to explore cutting-edge solutions for secure biomedical data processing. Register here!🔗 secured-project.eu/2nd-demo-wor...
- Reposted by Josep Carreras Leukaemia Research Institute[Not loaded yet]
- Reposted by Josep Carreras Leukaemia Research Institute[Not loaded yet]
- Our common goal: curing childhood leukaemia 🤝 The Josep Carreras Institute, the Josep Carreras Foundation and the Sant Joan de Déu Research Institute launch a joint programme to advance research into paediatric blood cancers 🔬 🔗 Read more: www.carrerasresearch.org/en/news/new-...
- 📢 La unidad de Comunicación del IJC ha sido acreditada como Unidad de Cultura Científica y de la Innovación (UCC+I) por #FECYT. Un paso clave para seguir acercando la ciencia a la sociedad🔬 🔗 www.carrerasresearch.org/es/noticias/...
- La Dra. Sònia Guil nos habla de su investigación en #SíndromeDeRett y del nuevo fármaco que están desarrollando con el objetivo de revertir sus síntomas. No te pierdas su entrevista en 'A golpe de bit' en #RNE 📻 Escúchala aquí 👇 www.rtve.es/play/audios/...
- Congratulations, Dr Obiols! 👩🔬 Mireia Obiols, researcher at the @jlsardinalab.bsky.social, has successfully defended her #PhD thesis today at the IJC Auditorium. Proud of your dedication and hard work 💪
- 🚨New research by @jlsardinalab.bsky.social and Gemma Valcarcel published at Science Advances uses a CRISPR technology to control immune cell response to inflammation in the lab. 🔗 Read more: www.carrerasresearch.org/en/news/epig...
- Last #YoungResearchers Seminars before the summer break! 👩🔬 Our talented researchers Mar Gusi (Maribel Parra's lab) and Alba Vidal (Anna Bigas' lab) gave excellent presentations yesterday, sharing their work to the rest of the IJC community. We’ll be back in September with more inspiring seminars✨
- 📢 Registration open! Explore the latest advances in cellular #senescence at the upcoming International Conference of @senescel.org 🧬 📅 06-07 November 2025 📍 Barcelona More information ⬇️ senescel2025.senescel.org Co-organised by IJC Group Leader Dr. Verónica Rodilla @vrodillab.bsky.social
- 🧬 New research from Pablo Menéndez's lab presents a novel CAR-T cells therapy designed to target 2️⃣ specific markers of T-ALL: the CD1a and CCR9 proteins. Preclinical results show high efficacy and safety in the lab. 🔗 carrerasresearch.org/en/news/a-ne... 🤝 ISS Aragon, OneChain Immunotherapeutics
- El Dr. @manelesteller.bsky.social , de l’IJC, i el Dr. @macips01.bsky.social reben el premi Jaume Aiguader i Miró de l'Acadèmia de Ciències Mèdiques i de la Salut per “El secret de la vida eterna” 📖 🔗 www.carrerasresearch.org/ca/noticies/...
- 💬🔬 Yesterday we held another inspiring Group Leaders Seminar at the Josep Carreras Institute Dr Tomàs Navarro and Dr Gaël Roué shared deep insights into the biology and treatment of B-Lymphomas 👏 Sharing science is key to moving forward together 🚀
- This Friday, do not miss Dr Rouault-Pierre's Invited Lecture! 💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells" 🗓️ 23 May, 12pm CEST 📍IJC Auditorium Online at 👉 us06web.zoom.us/webinar/regi...
- 🔬🌍 Today, on #ClinicalTrialsDay, we celebrate the power of research to save lives A hopeful milestone: In a phase I clinical trial, our new CAR-T therapy has shown promising results in patients with a highly resistant lymphoma 📄 Read the full story: www.carrerasresearch.org/en/news/new-...
- Yesteday we officially welcomed Dr Ari Melnick, the new Director of the Josep Carreras Institute. 💬 "I see us as a team united in our purpose to eradicate blood cancers." He reaffirmed his commitment to scientific progress and collaborative growth in front of #IJC community 🚀
- New study co-led by @manelesteller.bsky.social shows that epigenetic profiling identifies two distinct subtypes of Burkitt lymphoma, allowing early prediction of disease aggressiveness. This could help tailor treatment strategies from diagnosis. 🧬📈 👉 www.carrerasresearch.org/en/news/epig...
- ❗️🔬 New research from @scuartero.bsky.social's lab reveals that CEBPA mutations in #AML increase resistance to inflammation but make cells more vulnerable to protein-folding stress, opening the door to new treatment strategies. ➡️ www.carrerasresearch.org/en/news/a-co...
- New CD30-targeted CAR-T therapy shows 100% overall response and 50% complete remission in Refractory Hodgkin Lymphoma patients 👉 carrerasresearch.org/en/news/new-... 🔬 Led by Dr. Javier Briones, PI at #IJC and @irsantpau.bsky.social @hospitalsantpau.bsky.social 📝 @bloodjournal.bsky.social
- We're pleased to announce that Dr Ari Melnick has been appointed new Director of the Josep Carreras Institute. Dr Melnick will lead IJC in our mission to advance #research in #leukaemia and other malignant blood diseases. Read the full release here: www.carrerasresearch.org/en/news/dr-a...
- 🧬 Genetic susceptibility to cancer explained. New study by Eduard Porta's lab at @cellpress.bsky.social describes 119 germline variants with significant contribution to cancer onset and progession. ➡️ carrerasresearch.org/en/news/new-...
- Next week, we’re honoured to welcome to IJC Dr. Rainer Storb, a world-leading expert in haematology. "History of Allogeneic Hematopoietic Cell Transplantation as an Example of Intensive Bench-to-Bedside Research" 🗓️ 24 April - 12pm 📍 IJC Auditorium +Online 🔗 www.carrerasresearch.org/en/events/hi...
- La Dra. @bmjavierre.bsky.social ha sido reconocida con el prestigioso Premio CRIS Excelencia de #CRISContraElCáncerr 🏆 Gracias al programa, su grupo estudiará cómo el ADN 🧬se ve alterado en el tratamiento de la leucemia linfoblástica de células B y cómo esto puede llevar a recaídas.
- The #SingleCell Unit (SCU) provides state-of-the-art genomic & transcriptomic analysis at single-cell resolution. We help researchers uncover the full heterogeneity of complex diseases like blood cancers. www.carrerasresearch.org/en/units/sin...
- At IJC, we’re committed to promoting healthy habits in the workplace 🥦🍎🏃♂️ Thanks to #FundacióAlicia, our team has had the opportunity to gain practical insights on nutrition to support a healthier and more balanced lifestyle.
- 🚀 Empowering researchers accelerates science! 🧬💻Our #Bioinformatics Unit runs frequent training sessions, such as last weeks' #R for programming & data visualization, or this weeks' High Performance Computing (#HPC) for big data analysis Learn more👉 ijcbit.eu/training/
- 📣 On today's Young Researchers Seminars, Barbara Chalhoub 👩🔬 (Laura Mondragón's lab) discussed APAF-1 deficiency in tumor progression, while Víctor Sánchez 👨🔬 (@manelesteller.bsky.social) shared insights on novel treatments to enhance cancer immunotherapy 🧪🧫 Well done, young researchers!✨🔬
- #DíaMundialDeLaSalud la Unidad de Innovación trabaja para que la investigación se transforme en soluciones reales para los pacientes Trazan la mejor estrategia para transformar la investigación en soluciones tangibles para la sociedad. ✨Innovar es convertir ideas en impacto
- El Instituto Josep Carreras recibe la Acreditación Centros de @contracancerinv.bsky.social, un reconocimiento a la excelencia científica 🔬 y calidad en la gestión institucional ✨ 👉 carrerasresearch.org/es/noticias/...
- 🧬 New insights into #MDS & #TP53! 🔬 New study with the participation of @kikosole.bsky.social identified a subset of MDS patients with non-mutational p53 dysfunction, showing a distinct immunosuppressive profile, which may be one of the drivers of their poor prognosis.
- 🔬🧬 New research —featuring Lymphoma translational group led by Dr. Roué— reveals hat reducing TRIM24 levels can overcome bortezomib resistance in mantle cell lymphoma, restoring drug sensitivity and opening new treatment possibilities. 👉 Read more at carrerasresearch.org/en/news/rese...
- 🎯 Nueva diana terapéutica contra la #LMA 🔬 El laboratorio liderado por @marcusbuschbeck.bsky.social ha descubierto una proteína clave: su eliminación revierte la enfermedad sin dañar las células sanas. 🔗 lavanguardia.com/ciencia/2025... 📰 BigVan Ciència @lavanguardia.com 🤝 #FundacióLaCaixa
